4.82
price up icon17.85%   0.73
after-market Dopo l'orario di chiusura: 4.80 -0.02 -0.41%
loading
Precedente Chiudi:
$4.09
Aprire:
$4.08
Volume 24 ore:
2.36M
Relative Volume:
1.50
Capitalizzazione di mercato:
$127.74M
Reddito:
-
Utile/perdita netta:
$-30.26M
Rapporto P/E:
-2.3627
EPS:
-2.04
Flusso di cassa netto:
$-24.69M
1 W Prestazione:
+43.03%
1M Prestazione:
+135.12%
6M Prestazione:
+143.43%
1 anno Prestazione:
-31.82%
Intervallo 1D:
Value
$4.01
$4.83
Intervallo di 1 settimana:
Value
$3.25
$4.83
Portata 52W:
Value
$1.11
$7.39

Annovis Bio Inc Stock (ANVS) Company Profile

Name
Nome
Annovis Bio Inc
Name
Telefono
484-875-3192
Name
Indirizzo
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
Name
Dipendente
6
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-11
Name
Ultimi documenti SEC
Name
ANVS's Discussions on Twitter

Confronta ANVS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ANVS
Annovis Bio Inc
4.82 108.40M 0 -30.26M -24.69M -2.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
429.82 107.58B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
787.32 80.03B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
429.80 57.37B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
917.93 55.83B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
209.02 44.13B 447.02M -1.18B -906.14M -6.1812

Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-10 Downgrade D. Boral Capital Buy → Hold
2024-10-25 Aggiornamento Maxim Group Hold → Buy
2023-12-29 Iniziato Canaccord Genuity Buy
2021-07-07 Reiterato Maxim Group Buy

Annovis Bio Inc Borsa (ANVS) Ultime notizie

pulisher
01:20 AM

Alzheimer's Disease Market to Evolve Rapidly Over the Next - openPR.com

01:20 AM
pulisher
12:40 PM

Annovis Bio director Hoffman buys $159k in shares - Investing.com

12:40 PM
pulisher
02:00 AM

Parkinson’s Breakthrough? New Data Shows Drug May Reverse Cognitive Decline - MyChesCo

02:00 AM
pulisher
Nov 24, 2025

Annovis Announces Two Presentations at the CTAD 2025 Conference - The Manila Times

Nov 24, 2025
pulisher
Nov 22, 2025

Annovis Bio director Hoffman buys $69.9k in ANVS stock By Investing.com - Investing.com Nigeria

Nov 22, 2025
pulisher
Nov 21, 2025

Annovis Bio director Hoffman buys $69.9k in ANVS stock - Investing.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Annovis Bio Inc. stock attract long term capital inflows2025 Short Interest & Intraday High Probability Setup Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How Annovis Bio Inc. stock reacts to stronger dollarJuly 2025 Technicals & Long-Term Safe Investment Ideas - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Annovis Bio Inc Stock Analysis and ForecastDividend Stability Analysis & Small Budget Capital Growth - earlytimes.in

Nov 20, 2025
pulisher
Nov 20, 2025

How Annovis Bio Inc. stock reacts to monetary easingTake Profit & Verified Momentum Watchlists - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Annovis Bio Inc. stock fits value portfoliosWeekly Earnings Recap & Fast Entry Momentum Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can Annovis Bio Inc. stock deliver sustainable ROEWeekly Stock Report & Daily Volume Surge Trade Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Annovis Bio Inc. stock benefit from automationJuly 2025 Closing Moves & AI Forecasted Stock Moves - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Annovis Bio Inc. stock outperform Dow JonesShare Buyback & Detailed Earnings Play Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Annovis Bio Inc. stock is a must watch tickerShare Buyback & Scalable Portfolio Growth Ideas - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

How Annovis Bio Inc. stock compares with market leadersJuly 2025 Patterns & Community Supported Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Annovis Bio Inc. stock attractive for passive investors2025 Trade Ideas & AI Powered Market Entry Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Annovis Bio Inc. stock compares with top peers2025 Dividend Review & Free High Accuracy Swing Entry Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Annovis Stock Rises After Company Confirms Meeting With Regulators To Discuss Drug In Treating Parkinson's Disease Dementia - MSN

Nov 19, 2025
pulisher
Nov 19, 2025

Can momentum traders help lift Annovis Bio Inc.July 2025 PostEarnings & High Yield Stock Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

FDA to hear plan for buntanetap as Parkinson’s dementia treatment - Parkinson's News Today

Nov 19, 2025
pulisher
Nov 19, 2025

What does recent volatility data suggest for Annovis Bio Inc.July 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Annovis Bio Inc. stock volume spike explainedJuly 2025 Volume & Daily Stock Trend Watchlist - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Annovis Bio Inc. stock deliver consistent EPS growth2025 Price Action Summary & Intraday High Probability Setup Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Applying Wyckoff theory to Annovis Bio Inc. stockJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Annovis Rallies Around Phase 3 Alzheimer’s Push as New Data Signals Disease-Modifying Promise - MyChesCo

Nov 19, 2025
pulisher
Nov 19, 2025

Why retail traders accumulate Annovis Bio Inc. stockQuarterly Trade Summary & Daily Technical Stock Forecast Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How geopolitical risks impact Annovis Bio Inc. stockEarnings Overview Report & Accurate Technical Buy Alerts - newser.com

Nov 19, 2025

Annovis Bio Inc Azioni (ANVS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$39.54
price down icon 0.53%
$31.40
price up icon 1.88%
$105.55
price down icon 0.65%
$99.71
price up icon 3.28%
biotechnology ONC
$335.17
price up icon 0.74%
$209.02
price up icon 1.01%
Capitalizzazione:     |  Volume (24 ore):